Study of URG101 in Painful Bladder Syndrome and Interstitial Cystitis



Status:Completed
Conditions:Other Indications, Pain, Urology, Urology
Therapuetic Areas:Musculoskeletal, Nephrology / Urology, Other
Healthy:No
Age Range:18 - Any
Updated:10/20/2018
Start Date:August 2007
End Date:April 2008

Use our guide to learn which trials are right for you!

URG101 Pharmacodynamic and Safety Study: A Randomized, Double-blind, Placebo-controlled, Multi-center Cross-over Study to Investigate the Pharmacodynamic Profile of URG101 in Subjects With Pelvic Pain of Bladder Origin.

A double-blind, placebo-controlled study to evaluate changes in pain, urgency and urinary
frequency following administration of URG101 compared to placebo.


Inclusion Criteria:

- male and female subjects >= 18 years of age

- moderate to severe symptoms of PBS/IC

- minimum pain/urgency/frequency scores

- female subjects on hormone therapy must be on stable dose for >= 3 months

Exclusion Criteria:

- positive pregnancy test or pregnant or lactating

- narcotics or medical marijuana within 3 months

- use of any investigational drug or device within 30 days

- bacterial cystitis within 30 days
We found this trial at
6
sites
Glendora, California 91741
?
mi
from
Glendora, CA
Click here to add this to my saved trials
Cartersville, Georgia 30120
?
mi
from
Cartersville, GA
Click here to add this to my saved trials
San Antonio, Texas 78229
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
San Diego, California 92103
?
mi
from
San Diego, CA
Click here to add this to my saved trials
San Diego, California 92093
?
mi
from
San Diego, CA
Click here to add this to my saved trials
San Diego, California 92130
?
mi
from
San Diego, CA
Click here to add this to my saved trials